Conor McNamara
Stock Analyst at RBC Capital
(1.34)
# 3,652
Out of 5,105 analysts
141
Total ratings
35.92%
Success rate
-10.4%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Upgrades: Outperform | $61 → $73 | $58.51 | +24.77% | 11 | Sep 3, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $7 → $5 | $3.60 | +38.89% | 7 | Aug 12, 2025 | |
| NTRA Natera | Maintains: Outperform | $251 → $255 | $231.95 | +9.94% | 2 | Aug 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $4 → $3 | $2.15 | +39.53% | 4 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Sector Perform | $54 → $46 | $101.50 | -54.68% | 1 | Aug 7, 2025 | |
| HOLX Hologic | Upgrades: Outperform | $72 → $87 | $75.00 | +16.00% | 12 | Aug 6, 2025 | |
| AVTR Avantor | Maintains: Outperform | $20 → $17 | $11.17 | +52.19% | 9 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Outperform | $118 → $126 | $134.87 | -6.58% | 16 | Aug 1, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $308.13 | +32.74% | 14 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $309.22 | +32.27% | 14 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $193 → $204 | $157.39 | +29.61% | 12 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $651 → $637 | $572.28 | +11.31% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $250 | $226.33 | +10.46% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $28.80 | +111.81% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $4.75 | +47.37% | 4 | Aug 7, 2024 |
Bio-Techne
Sep 3, 2025
Upgrades: Outperform
Price Target: $61 → $73
Current: $58.51
Upside: +24.77%
Maravai LifeSciences Holdings
Aug 12, 2025
Maintains: Outperform
Price Target: $7 → $5
Current: $3.60
Upside: +38.89%
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251 → $255
Current: $231.95
Upside: +9.94%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4 → $3
Current: $2.15
Upside: +39.53%
Exact Sciences
Aug 7, 2025
Maintains: Sector Perform
Price Target: $54 → $46
Current: $101.50
Upside: -54.68%
Hologic
Aug 6, 2025
Upgrades: Outperform
Price Target: $72 → $87
Current: $75.00
Upside: +16.00%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $11.17
Upside: +52.19%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118 → $126
Current: $134.87
Upside: -6.58%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $308.13
Upside: +32.74%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $309.22
Upside: +32.27%
Jul 30, 2025
Maintains: Outperform
Price Target: $193 → $204
Current: $157.39
Upside: +29.61%
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $572.28
Upside: +11.31%
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $226.33
Upside: +10.46%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $28.80
Upside: +111.81%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $4.75
Upside: +47.37%